Mesoblast
MESO
10.89
-0.29
-2.59%
Mesoblast
US · MESO
#2849 by market cap
Listed 2015
10.89
-0.29
-2.59%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $11Market Newswire · 2024/10/31
-
Rating change
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $18Market Newswire · 2024/11/6
-
Company notice
MESO NUMISMATICS INC | 8-K: Current reportSEC · 2024/5/23
-
Company notice
MESO NUMISMATICS INC | 10-Q: Q1 2024 Earnings ReportSEC · 2024/5/21
-
Rating change
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $30Market Newswire · 2025/9/6
-
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $35Market Newswire · 2026/4/10
-
Rating change
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $35Market Newswire · 2025/10/9
-
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $39Market Newswire · 2026/8/27
-
Rating change
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2024/12/21
-
Company notice
MESO NUMISMATICS INC | 10-Q: Q2 2024 Earnings ReportSEC · 2024/8/15
-
Rating change
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Announces Target Price $11Market Newswire · 2024/8/29
-
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $35Market Newswire · 2026/3/2
-
Company notice
MESO NUMISMATICS INC | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filingSEC · 2024/8/23
-
Company notice
MESO NUMISMATICS INC | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSBSEC · 2024/5/15
-
Mesoblast (MESO.US) will release its earnings report after the market close on August 26.Market Newswire · 2026/8/24
-
Rating change
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $24Market Newswire · 2025/2/7
-
Rating change
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $30Market Newswire · 2024/12/21
-
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $35Market Newswire · 2026/9/26
-
Rating change
Maxim Group Upgrades Mesoblast(MESO.US) to Buy Rating, Cuts Target Price to $12Market Newswire · 2024/9/24
-
Rating change
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $24Market Newswire · 2025/9/10
-
Rating change
Piper Sandler Upgrades Mesoblast(MESO.US) to Buy RatingMarket Newswire · 2024/7/24
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Mesoblast discussion 0 comments